interferon

A CHANGER      

Select            
Trial Studied trt Control trt patientstagsROB Trial resultprogression or death (progression free survival PFS) death (overall survival)

melanoma

Interferon alpha
EORTC18952 (Eggermont), 2005   ID IFN alpha-2b (I M)observationadjuvantnegative-16%-16%
Nordic IFN Trial, 2011     ID IFN alpha-2b (I M)observationadjuvantsuggesting-23%-9%
EORTC18991 (Eggermont), 2008   PEG IFN alpha-2b (I M)observationadjuvantsuggesting-13%-4%
EORTC18871/DKG 80-1 (Kleeberg), 2004   rIFN alpha-2bobservationadjuvantnegative4%-4%